CALR and cancer: Since accelerated Mev-pathway affects the translocation on the cell surface of Calreticulin (CRT), an hallmark of ICD, NBP-mediated interruption of Mev-pathway could be also an effective strategy to promote the sensitivity of cancer cells to ICD (157).